Literature DB >> 10377518

Procalcitonin--a novel biochemical marker for the mediator-directed therapy of sepsis.

S Russwurm, M Oberhoffer, P F Zipfel, K Reinhart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10377518     DOI： 10.1016/s1357-4310(99)01505-1

Source DB:  PubMed          Journal:  Mol Med Today        ISSN： 1357-4310


× No keyword cloud information.
  4 in total

1.  Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis.

Authors:  Bettina Rau; Gerald Steinbach; Colin M Krüger; Katja Baumgart; Martin Schilling; Hans G Beger
Journal:  Langenbecks Arch Surg       Date:  2003-07-11       Impact factor: 3.445

2.  Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

Authors:  Kowoon Joo; Won Park; Mie-Jin Lim; Seong-Ryul Kwon; Jiyeol Yoon
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

3.  Procalcitonin as a biomarker in equine chronic pneumopathies.

Authors:  Ann Kristin Barton; Anna Pelli; Martin Rieger; Heidrun Gehlen
Journal:  BMC Vet Res       Date:  2016-12-09       Impact factor: 2.741

4.  Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.

Authors:  Amanda G Blouin; Meier Hsu; Martin Fleisher; Lakshmi V Ramanathan; Stephen M Pastores
Journal:  Clin Chim Acta       Date:  2020-07-15       Impact factor: 3.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.